This phase 3 trial randomized treatment-naïve NSCLC patients with classic EGFR...
The regimen which combines lenvatinib with pembrolizumab, has become...
In this episode of WND Breast, Dr Kevin Punie of GZA Hospitals and Prof Evandro...
The absence of efficacious interventions for advanced, chemotherapy-refractory...
Professor Mariana Brandao, a medical oncologist at Institut Jules Bordet in...
Prof Vulsteke from Maria Middelares Gent will present the CheckMate901 study,...
Professor Evandro de Azambuja from Institut Jules Bordet and Dr Kevin Punie...
Prof Mariana Brandao and Prof Johan Vansteenkiste discuss the FLAURA2 trial...
Professor Vulsteke from Maria Middelares Gent will discuss the SunRISE-1 study,...
KEYNOTE-522, a widely recognized phase 3 trial, has led to a paradigm shift in...